REPORTS

Let’s Pullulate and Expand Your Business

Transdermal Skin Patches Market - Global Professional Analysis and Forecast to 2026

Nov 15, 2019  |  139 PAGES  |  REPORT CODE: CMM238198
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Transdermal Skin Patches market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.0% during the forecast period.

This report presents the market size and development trends by detailing the Transdermal Skin Patches market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Transdermal Skin Patches market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Transdermal Skin Patches industry and will help you to build a panoramic view of the industrial development.

Transdermal Skin Patches Market, By Type:

  • Drug in Adhesive

  • Matrix

  • Reservoir

  • Vapor

  • Other

Transdermal Skin Patches Market, By Application:

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

Some of the leading players are as follows:

  • Teva Pharmaceutical Industries

  • Johnson & Johnson

  • Mundipharma International

  • ProSolus, Inc.

  • Accrux Ltd.

  • Access Pharmaceuticals Inc.

  • Medipatch, Inc.

  • 3M Company

  • Novartis AG

  • AdhexPharma

  • Mylan N.V.

  • Purdue Pharma

  • Hisamitsu Pharmaceutical

  • Luye Pharma Group

  • Abbott Laboratories

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Transdermal Skin Patches Market: Technology Type Analysis

  • 4.1 Transdermal Skin Patches Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Transdermal Skin Patches Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Drug in Adhesive

    • 4.3.2 Matrix

    • 4.3.3 Reservoir

    • 4.3.4 Vapor

    • 4.3.5 Other

5 Transdermal Skin Patches Market: Product Analysis

  • 5.1 Transdermal Skin Patches Product Market Share Analysis, 2018 & 2026

  • 5.2 Transdermal Skin Patches Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Transdermal Skin Patches Market: Application Analysis

  • 6.1 Transdermal Skin Patches Application Market Share Analysis, 2018 & 2026

  • 6.2 Transdermal Skin Patches Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospital Pharmacies

    • 6.3.2 Retail Pharmacies

    • 6.3.3 Online Pharmacies

7 Transdermal Skin Patches Market: Regional Analysis

  • 7.1 Transdermal Skin Patches Regional Market Share Analysis, 2018 & 2026

  • 7.2 Transdermal Skin Patches Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Teva Pharmaceutical Industries

    • 9.1.1 Teva Pharmaceutical Industries Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Johnson & Johnson

    • 9.2.1 Johnson & Johnson Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Mundipharma International

    • 9.3.1 Mundipharma International Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 ProSolus, Inc.

    • 9.4.1 ProSolus, Inc. Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Accrux Ltd.

    • 9.5.1 Accrux Ltd. Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Access Pharmaceuticals Inc.

    • 9.6.1 Access Pharmaceuticals Inc. Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Medipatch, Inc.

    • 9.7.1 Medipatch, Inc. Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 3M Company

    • 9.8.1 3M Company Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Novartis AG

    • 9.9.1 Novartis AG Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 AdhexPharma

    • 9.10.1 AdhexPharma Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Mylan N.V.

    • 9.11.1 Mylan N.V. Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Purdue Pharma

    • 9.12.1 Purdue Pharma Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Hisamitsu Pharmaceutical

    • 9.13.1 Hisamitsu Pharmaceutical Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Luye Pharma Group

    • 9.14.1 Luye Pharma Group Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Abbott Laboratories

    • 9.15.1 Abbott Laboratories Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

 

The List of Tables and Figures (Totals 73 Figures and 122 Tables)

  • Figure Drug in Adhesive Transdermal Skin Patches market, 2015 - 2026 (USD Million)

  • Figure Matrix Transdermal Skin Patches market, 2015 - 2026 (USD Million)

  • Figure Reservoir Transdermal Skin Patches market, 2015 - 2026 (USD Million)

  • Figure Vapor Transdermal Skin Patches market, 2015 - 2026 (USD Million)

  • Figure Other Transdermal Skin Patches market, 2015 - 2026 (USD Million)

  • Figure Hospital Pharmacies market, 2015 - 2026 (USD Million)

  • Figure Retail Pharmacies market, 2015 - 2026 (USD Million)

  • Figure Online Pharmacies market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Transdermal Skin Patches market, by country, 2015 - 2026 (USD Million)

  • Table North America Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table North America Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table North America Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table Canada Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table Canada Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Europe Transdermal Skin Patches market, by country, 2015 - 2026 (USD Million)

  • Table Europe Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table Europe Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table Europe Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table Germany Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table Germany Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table France Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table France Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table Italy Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table Italy Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table Spain Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table Spain Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Transdermal Skin Patches market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table China Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table China Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table Japan Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table Japan Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table India Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table India Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Transdermal Skin Patches market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table MEA Transdermal Skin Patches market, by country, 2015 - 2026 (USD Million)

  • Table MEA Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table MEA Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table MEA Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Transdermal Skin Patches market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Transdermal Skin Patches market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Transdermal Skin Patches market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Teva Pharmaceutical Industries Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mundipharma International Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ProSolus, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Accrux Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Access Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Medipatch, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table 3M Company Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AdhexPharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mylan N.V. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Purdue Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Hisamitsu Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Luye Pharma Group Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top